Chongfan Technology
News
07
2024
-
08
Nat Immunol | Fudan University Zhou Zhaacai/Jiao Shi shows that p97-Npl4 complex plays an important role in controlling the balance of Treg-TH17 cells in tumors
Author:
Targeting tumor-infiltrating regulatory T cells (TI-Treg) is a potential cancer treatment strategy. Complexes of ATPase p97 with cofactors (such as Npl4) have been studied as targets for anti-tumor drugs; however, whether p97 plays a role in immune cells or immunotherapy is unclear.
On August 6, 2024, Zhou Zhaocai and Jiao Shi of Fudan University jointly communicated inNature Immunology(IF=27.7)Published online entitled“Targeting p97–Npl4 interaction inhibits tumor Treg cell development to enhance tumor immunity”The research paper,The studyIt is proved that tunzobromide (thonzonium bromide) is an inhibitor of the interaction between p97 and Npl4, and this p97-Npl4 complex in TI-TregIt has key functions in cells.
Tonzobromide enhances antitumor immunity without affecting peripheral Tregcellular homeostasis. p97-Npl4 complexes link Stat3 with the E3 ligases PDLIM2 and PDLIM5, thereby promoting Stat3 degradation and enablingTI-T reg.Cell development.Collectively, this work shows the p97-Npl4 complex in controlling tumor Treg-T H17 important role in cellular homeostasis and identified possible targets for immunotherapy.
TI-Tregcells are abundant in tumor tissue and inhibit the antitumor response, especially by traditional T (Tconv) cell-mediated antitumor response.TI-T in the tumor microenvironment (tumor microenvironment, TME)regIncreased cell number and Tconv/TI-TregA reduced ratio of cell numbers is associated with a poor prognosis for many cancers.TI-TregCells utilize multiple mechanisms, including the production of immunosuppressive cytokines (such as interleukin (IL)-10 and transforming growth factor (TGF)-β) and the expression of immune checkpoint molecules (such as CTLA-4, PD-1, and TIGIT), to inhibit TconvCell function, establish an immunosuppressive TME, protect cancer cells from immune surveillance, thereby promoting tumor development, and may in some cases lead to tumor hyper-progression during immune checkpoint blockade therapy.

Blocking p97-Npl4 interactions inhibits TI-Tregcell infiltration and differentiation
Zhou Zhaocai and Jiao Shi, professors of the School of Life Sciences of Fudan University, are the co-authors of the paper; researchers from Fudan University, Tongji University and the First Affiliated Hospital of Kunming Medical University jointly completed the study; postdoctoral Nie Pingping and Cao Zhifa, doctoral student Yu Ruixian, and Dr. Dong Chao, director of the Department of Oncology, are the co-first authors of the paper. Professor Yufang from Suzhou University, Professor Li Bin from Shanghai Jiaotong University, researcher Liu Xiaolong and researcher Zhao Yun from the Center for Excellence in Molecular Cell Science of the Chinese Academy of Sciences, and researcher Wang Ying from the Shanghai Institute of Nutrition and Health of the Chinese Academy of Sciences provided strong support for the research.
Chongqing Chongfan Technology Co., Ltd. Optical platform film thickness meter OCT optical coherence tomography LabVIEW control
Previous
Previous
LATEST NEWS
Thank you for visiting the official website of Chongfan Technology. If you have cooperation intentions or suggestions, please contact us through the following methods, and we will reply as soon as possible, thank you!
Address: Room 403, Building 6, Phase III of R&D, No. 36 Xiyong Avenue, High tech Zone, Chongqing, China.
Telephone: +86-13658337211
E-mail: Sales@cfkeji.net
Website: www.cfkeji.net
Mobile Version